Full name
LUMIBIRD MEDICAL POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.74.Z - Retail sale of medical and orthopedic products
68 - Real estate activities
70 - Head office activities and management consultancy
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
77 - Rental and leasing
82 - Office administrative support activities and other business support services
2019 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 3,2 | 4,2 | 33,2 |
EBITDA | 0,9 | 3,2 | 4,3 | 32,3 |
Short time liabilities | 0,9 | 1,7 | 1,5 | -12,1 |
Equity capital | 1,5 | 6,6 | 9,9 | 51,2 |
Operating profit (EBIT) | 0,9 | 3,2 | 4,2 | 31,6 |
Assets | 2,5 | 8,4 | 11,4 | 35,8 |
Net profit (loss) | 0,7 | 2,5 | 3,4 | 32,9 |
Cash | 0,4 | 4,3 | 6 | 40,3 |
Liabilities and provisions for liabilities | 1 | 1,8 | 1,5 | -19,2 |
Net income from sale | 8,3 | 14,7 | 18,8 | 28,4 |
Working assets | 2,5 | 8,3 | 11,3 | 35,4 |
Depreciation | 0 | 0 | 0 | 380,8 |
% | % | % | p.p. | |
Profitability of capital | 44,8 | 38,6 | 33,9 | -4,7 |
Equity capital to total assets | 59,5 | 78,2 | 87 | 8,8 |
Gross profit margin | 10,1 | 21,5 | 22,3 | 0,8 |
EBITDA Margin | 10,6 | 21,9 | 22,6 | 0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 42 | 29 | -13 |
Current financial liquidity indicator | 2.6383814811706543 | 4.95365571975708 | 7.632308006286621 | 2,6 |
Net dept to EBITDA | -0.4142517149448395 | -1.3241502046585083 | -1.40434992313385 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane